INTEGRATED BIOPHARMA INC
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2011 | $40.7M | $-362.0K | $-2.3M |
| FY2012 | $36.6M | $-506.0K | $-2.7M |
| FY2013 | $33.6M | $1.1M | $93.0K |
| FY2014 | $33.7M | $1.4M | $131.0K |
| FY2015 | $37.5M | $933.0K | $735.0K |
| FY2016 | $42.2M | $2.1M | $958.0K |
| FY2017 | $47.0M | $3.2M | $2.3M |
| FY2018 | $43.7M | $1.7M | $679.0K |
| FY2019 | $50.0M | $2.7M | $1.7M |
| FY2020 | $52.8M | $3.3M | $4.1M |
| FY2021 | $63.6M | $5.8M | $8.0M |
| FY2022 | $56.2M | $2.7M | $3.8M |
| FY2023 | $50.7M | $120.0K | $-34.0K |
| FY2024 | $50.3M | $251.0K | $112.0K |
| FY2025 | $54.4M | $2.0M | $808.0K |
Abnormally good or abnormally bad conditions do not last forever.